Hepatic ethanol elimination kinetics in patients with cirrhosis

被引:11
|
作者
Dam, Gitte [1 ,2 ]
Sorensen, Michael [1 ,2 ]
Munk, Ole Lajord [1 ]
Keiding, Susanne [1 ,2 ]
机构
[1] Aarhus Univ Hosp, PET Ctr, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Med Hepatol, DK-8000 Aarhus, Denmark
关键词
Alcoholism; alcohol dehydrogenase; liver metabolism; liver pathophysiology; microsomal ethanol oxidizing system; OXIDIZING SYSTEM MEOS; ALCOHOL-DEHYDROGENASE; INDOCYANINE GREEN; BLANK DENSITY; HUMAN-LIVER; METABOLISM; CLEARANCE; INCREASE; INVIVO; PLASMA;
D O I
10.1080/00365520902929856
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective. To address the question of whether increased ethanol elimination in alcoholics can be ascribed to increased metabolism via alcohol dehydrogenase (ADH; K-m around 0.2 mM) or the microsomal ethanol-oxidizing system (MEOS,K-m 10 mM) by kinetic analysis of hepatic ethanol elimination in recently drinking patients with alcoholic cirrhosis and healthy subjects. A further objective was to investigate whether systemic clearance of ethanol at low arterial ethanol concentrations can be used as a measure of hepatic blood flow. Material and methods. Six patients with alcoholic cirrhosis were enrolled after 2 days of abstinence, along with 6 healthy subjects. Ethanol was administered as 6 successive infusions in increasing doses. Arterial and hepatic venous blood concentrations of ethanol were measured; hepatic blood flow was measured simultaneously. Kinetic parameters were calculated according to the sinusoidal perfusion model of enzymatic elimination by the intact liver. Results. Mean hepatic K-m for ethanol was 0.16 mM (range 0.09-0.36) in healthy subjects and 0.36 mM (range 0.16-0.69) in patients with cirrhosis (p > 0.3), both compatible with the K-m for ADH. The two groups of subjects had similar V-max values (p > 0.3). Extrahepatic elimination of ethanol accounted for more than 50% of total elimination in both groups, which precludes the use of systemic clearance as a measure of hepatic blood flow. Conclusions. The results support the hypothesis that ADH remains the main pathway for hepatic elimination of ethanol in recently drinking patients with alcoholic cirrhosis. We interpret this as evidence against a significant contribution of MEOS in vivo.
引用
收藏
页码:867 / 871
页数:5
相关论文
共 50 条
  • [31] Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy
    Singh, Jatinderpal
    Sharma, Barjesh Chander
    Puri, Vinod
    Sachdeva, Sanjeev
    Srivastava, Siddharth
    METABOLIC BRAIN DISEASE, 2017, 32 (02) : 595 - 605
  • [32] Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?
    Gairing, Simon Johannes
    Schleicher, Eva Maria
    Labenz, Christian
    METABOLIC BRAIN DISEASE, 2023, 38 (05) : 1691 - 1700
  • [33] Prednisolone but Not Infliximab Aggravates the Upregulated Hepatic Nitrogen Elimination in Patients with Active Inflammatory Bowel Disease
    Thomsen, Karen L.
    Gronbk, Henning
    Dahlerup, Jens F.
    Aagaard, Niels K.
    Christensen, Lisbet A.
    Agnholt, Jorgen
    Frystyk, Jan
    Vilstrup, Hendrik
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (01) : 7 - 13
  • [34] Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis
    Sharma, Praveen
    Sharma, Barjesh Chander
    Sarin, Shiv Kumar
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2010, 9 (01) : 27 - 32
  • [35] Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis
    Bahr, Matthias J.
    Boeker, Klaus H. W.
    Manns, Michael P.
    Tietge, Uwe J. F.
    CLINICAL ENDOCRINOLOGY, 2009, 70 (01) : 60 - 65
  • [36] Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon
    Zharikova, Olga L.
    Ravindran, Selvan
    Nanovskaya, Tatiana N.
    Hill, Ronald A.
    Hankins, Gary D. V.
    Ahmed, Mahmoud S.
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (12) : 2012 - 2019
  • [37] RELATIONSHIP BETWEEN CONTENT OF HEPATIC GLUTATHIONE S-TRANSFERASES AND THE KINETICS OF INDOCYANINE GREEN ELIMINATION IN VARIOUS LIVER-DISEASES
    SUGIMOTO, M
    SHIMADA, N
    AIKAWA, K
    SUGIYAMA, Y
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1993, 14 (07) : 567 - 578
  • [38] Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis
    Schytte, S
    Hansen, M
    Moller, S
    Junker, P
    Henriksen, JH
    Hillingso, J
    Teisner, B
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1999, 59 (08) : 627 - 633
  • [39] The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study
    Jepsen, Peter
    Vilstrup, Hendrik
    Ott, Peter
    Keiding, Susanne
    Andersen, Per K.
    Tygstrup, Niels
    BMC GASTROENTEROLOGY, 2009, 9
  • [40] Regional metabolic liver function measured in patients with cirrhosis by 2-[18F]fluoro-2-deoxy-D-galactose PET/CT
    Sorensen, Michael
    Mikkelsen, Kasper S.
    Frisch, Kim
    Villadsen, Gerda E.
    Keiding, Susanne
    JOURNAL OF HEPATOLOGY, 2013, 58 (06) : 1119 - 1124